🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury

RecruitingNAAges 18 Years - 65 YearsAllAnkara City Hospital Bilkent
NCT07343583 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Suprasacral spinal cord injury (SCI) frequently leads to neurogenic detrusor overactivity (NDO), resulting in elevated bladder storage pressures, urinary incontinence, and an increased risk of upper urinary tract damage. Early regulation of bladder function is a key objective of SCI rehabilitation, particularly during the subacute phase when pathological spinal reflex pathways are still developing. Pharmacological treatments are considered first-line therapy for NDO; however, adequate control may not be achieved in all patients, and treatment tolerance may be limited. Non-invasive neuromodulation techniques have emerged as alternative or adjunctive approaches for managing lower urinary tract dysfunction, but evidence regarding their effectiveness in SCI-related NDO-especially when applied during the subacute period-remains limited. This prospective randomized comparative study aims to

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. ≥18-65 years of age 2. Injury duration \<6 months 3. Traumatic and non-traumatic SCI; 4. Patients with spinal cord injury above T11 Exclusion Criteria: 1. Patients with a cardiac pacemaker 2. Patients with other neurological diseases that may affect neurogenic bladder (Parkinson's disease, polyneuropathy, neurodegenerative disease, cerebrovascular disease, etc.) 3. Patients with structural abnormalities in the genitourinary system (pelvic floor dysfunction, BPH, etc.) 4. Patients with acute urinary tract infection 5. Patients with a history of pelvic fracture associated with SCI 6. Patients using medications that may affect NDO (anticholinergic-sympathomimetic, etc.) 7. Patients who have undergone another neuromodulation technique after injury 8. Patients who have previously undergone pelvic radiation, bladder cancer, or other surgical procedures performed on the bladder that may affect bladder physiology will not be included in the study.
💊

What it tests

  • Transcutaneous Tibial Nerve Stimulation
  • Transcutaneous Sacral Nerve Stimulation
📍

Where

1 site
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy